ACHN

ACHILLION PHARMACEUTICALS INCCIK 1070336 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for ACHN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for ACHN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
MANNING MARTHA E	General Counsel	10	$10.2K	$0	2020-01-29
Di Donato Brian	SVP, Chief Financial Officer	3	$0	$0	2020-01-28
Gibney Anthony S	EVP, Chief Business Officer	4	$0	$0	2020-01-28
Firuta Paul E	EVP, Chief Commercial Officer	4	$0	$0	2020-01-28
Zelenkofske Steven	EVP, Chief Medical Officer	4	$0	$0	2020-01-28
Verwiel Frank	Director	9	$0	$0	2020-01-28
Truitt Joseph	SVP, Chief Commercial Officer	38	$14.2K	$1.62M	2020-01-28
SUSQUEHANNA SECURITIES, LLC	10% Owner	2	$0	$0	2020-01-28
Graves Kurt	Director	15	$0	$0	2020-01-28
Scheer David	Director	21	$0	$66.2K	2020-01-28
VAN NOSTRAND ROBERT L	Director	19	$0	$0	2020-01-28
FISHERMAN JASON S	Director	28	$268.3K	$0	2020-01-28
VITULLO NICOLE	Director, 10% Owner	46	$0	$5.96M	2020-01-28
KISHBAUCH MICHAEL D	Director	40	$0	$11.06M	2020-01-28
Lantz Keri	See Remarks	1	$0	$0	2019-01-23
Fenton Mary Kay	SVP and CFO	18	$10.3K	$816.8K	2018-02-09
Deshpande Milind	President of R&D and CSO	31	$10.1K	$3.82M	2018-02-09
FRASHIER GARY E	Director	33	$0	$1.10M	2018-02-09
Johnson & Johnson Innovation - JJDC, Inc.	10% Owner	1	$0	$50.51M	2017-11-20
Barrish Joel C	Chief Scientific Officer	4	$10.1K	$0	2017-01-17
Apelian David	EVP and Chief Medical Officer	9	$0	$105.0K	2017-01-17
Liotta Dennis	Director	8	$344.3K	$0	2014-12-02
Shah Gautam	SVP and Chief Compliance Ofc.	39	$0	$1.44M	2014-12-02
RA Capital Healthcare Fund LP	Other	54	$4.75M	$55.39M	2014-09-30
RA CAPITAL MANAGEMENT, LLC	10% Owner	55	$28.62M	$74.32M	2014-09-26
Kolchinsky Peter	10% Owner	48	$10.66M	$34.75B	2014-09-23
QVT Associates GP LLC	10% Owner	36	$16.65M	$27.47M	2014-06-16
QVT Fund V LP	10% Owner	7	$5.72M	$0	2013-08-09
Domain Partners VIII, L.P.	10% Owner	2	$0	$0	2013-01-18
Halak Brian K	10% Owner	4	$0	$0	2013-01-18
SCHOEMAKER KATHLEEN K	10% Owner	4	$0	$0	2013-01-18
DOVEY BRIAN H	10% Owner	4	$0	$0	2013-01-18
BLAIR JAMES C	10% Owner	4	$0	$0	2013-01-18
TREU JESSE I	10% Owner	4	$0	$0	2013-01-18
WRIGHT DAVID P	Director	4	$0	$64.3K	2012-12-18
Simon Nicholas	Director	2	$0	$0	2012-06-04
GALAKATOS NICHOLAS	10% Owner	1	$0	$0	2012-06-04
HENNER DENNIS	10% Owner	6	$0	$9.86M	2012-05-31
Olek Elizabeth A	SVP and CMO	3	$0	$125.4K	2012-01-10

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
MANNING MARTHA E	General Counsel	D To issuer deriv	2020-01-29	2020-01-29	110,000	—	$0	0	SEC↗
MANNING MARTHA E	General Counsel	D To issuer deriv	2020-01-29	2020-01-29	135,000	—	$0	0	SEC↗
Di Donato Brian	SVP, Chief Financial Officer	D To issuer deriv	2020-01-28	2020-01-29	500,000	—	$0	0	SEC↗
Di Donato Brian	SVP, Chief Financial Officer	D To issuer deriv	2020-01-28	2020-01-29	200,000	—	$0	0	SEC↗
Firuta Paul E	EVP, Chief Commercial Office	D To issuer deriv	2020-01-28	2020-01-29	200,000	—	$0	0	SEC↗
Firuta Paul E	EVP, Chief Commercial Office	D To issuer deriv	2020-01-28	2020-01-29	400,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer deriv	2020-01-28	2020-01-29	25,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer deriv	2020-01-28	2020-01-29	42,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer deriv	2020-01-28	2020-01-29	20,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer deriv	2020-01-28	2020-01-29	50,000	—	$0	0	SEC↗
Gibney Anthony S	EVP, Chief Business Officer	D To issuer deriv	2020-01-28	2020-01-29	200,000	—	$0	0	SEC↗
Gibney Anthony S	EVP, Chief Business Officer	D To issuer deriv	2020-01-28	2020-01-29	500,000	—	$0	0	SEC↗
Graves Kurt	Director	D To issuer deriv	2020-01-28	2020-01-29	25,000	—	$0	0	SEC↗
Graves Kurt	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Graves Kurt	Director	D To issuer deriv	2020-01-28	2020-01-29	135,000	—	$0	0	SEC↗
Graves Kurt	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Graves Kurt	Director	D To issuer deriv	2020-01-28	2020-01-29	42,000	—	$0	0	SEC↗
Graves Kurt	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
KISHBAUCH MICHAEL D	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
KISHBAUCH MICHAEL D	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
KISHBAUCH MICHAEL D	Director	D To issuer deriv	2020-01-28	2020-01-29	25,000	—	$0	0	SEC↗
KISHBAUCH MICHAEL D	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
KISHBAUCH MICHAEL D	Director	D To issuer deriv	2020-01-28	2020-01-29	6,250	—	$0	0	SEC↗
KISHBAUCH MICHAEL D	Director	D To issuer deriv	2020-01-28	2020-01-29	42,000	—	$0	0	SEC↗
MANNING MARTHA E	General Counsel	D To issuer deriv	2020-01-28	2020-01-29	150,000	—	$0	0	SEC↗
MANNING MARTHA E	General Counsel	D To issuer deriv	2020-01-28	2020-01-29	215,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2020-01-28	2020-01-29	50,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2020-01-28	2020-01-29	25,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2020-01-28	2020-01-29	42,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2020-01-28	2020-01-29	20,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	632,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	185,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	100,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	142,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	200,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	419,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	1,097,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer deriv	2020-01-28	2020-01-29	87,766	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer deriv	2020-01-28	2020-01-29	20,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer deriv	2020-01-28	2020-01-29	42,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer deriv	2020-01-28	2020-01-29	25,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer deriv	2020-01-28	2020-01-29	50,000	—	$0	0	SEC↗
Verwiel Frank	Director	D To issuer deriv	2020-01-28	2020-01-29	42,000	—	$0	0	SEC↗
Verwiel Frank	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Verwiel Frank	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Verwiel Frank	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
Zelenkofske Steven	EVP, Chief Medical Officer	D To issuer deriv	2020-01-28	2020-01-29	500,000	—	$0	0	SEC↗
Zelenkofske Steven	EVP, Chief Medical Officer	D To issuer deriv	2020-01-28	2020-01-29	200,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	50,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	20,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	20,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	25,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	25,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	42,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	D To issuer deriv	2020-01-28	2020-01-29	30,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	D To issuer	2020-01-28	2020-01-29	90,000	$6.30	$567.0K	0	SEC↗
FISHERMAN JASON S	Director	D To issuer	2020-01-28	2020-01-29	1,500	$6.30	$9.4K	0	SEC↗
Graves Kurt	Director	D To issuer	2020-01-28	2020-01-29	22,709	$6.30	$143.1K	0	SEC↗
MANNING MARTHA E	General Counsel	D To issuer	2020-01-28	2020-01-29	2,500	$6.30	$15.8K	0	SEC↗
Scheer David	Director	D To issuer	2020-01-28	2020-01-29	63,249	$6.30	$398.5K	0	SEC↗
Scheer David	Director	D To issuer	2020-01-28	2020-01-29	29,515	$6.30	$185.9K	0	SEC↗
Truitt Joseph	Chief Executive Officer	D To issuer	2020-01-28	2020-01-29	3,500	$6.30	$22.1K	0	SEC↗
VAN NOSTRAND ROBERT L	Director	D To issuer	2020-01-28	2020-01-29	40,000	$6.30	$252.0K	0	SEC↗
VITULLO NICOLE	Director	D To issuer	2020-01-28	2020-01-29	25,159	$6.30	$158.5K	0	SEC↗
VITULLO NICOLE	Director	D To issuer	2020-01-28	2020-01-29	36,431	$6.30	$229.5K	0	SEC↗
VITULLO NICOLE	Director	D To issuer	2020-01-28	2020-01-29	3,393,382	$6.30	$21.38M	0	SEC↗
SUSQUEHANNA SECURITIES, LLC	10% Owner	J Other	2020-01-28	2020-01-30	14,115,498	$6.30	$88.93M	0	SEC↗
SUSQUEHANNA SECURITIES, LLC	10% Owner	J Other	2020-01-28	2020-01-30	10,917	$6.30	$68.8K	0	SEC↗
VAN NOSTRAND ROBERT L	Director	M Exercise deriv	2019-12-18	2019-12-19	20,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	M Exercise	2019-12-18	2019-12-19	20,000	$3.28	$65.6K	40,000	SEC↗
FISHERMAN JASON S	Director	M Exercise deriv	2019-11-14	2019-11-14	20,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	M Exercise	2019-11-14	2019-11-14	20,000	$3.28	$65.6K	90,000	SEC↗
Scheer David	Director	M Exercise deriv	2019-11-13	2019-11-14	20,000	—	$0	0	SEC↗
Scheer David	Director	M Exercise	2019-11-13	2019-11-14	20,000	$3.28	$65.6K	40,000	SEC↗
Scheer David	Director	S Sale	2019-11-13	2019-11-14	10,485	$6.31	$66.2K	29,515	SEC↗
Truitt Joseph	Chief Executive Officer	M Exercise deriv	2019-10-16	2019-10-18	100,234	—	$0	87,766	SEC↗
Truitt Joseph	Chief Executive Officer	M Exercise deriv	2019-10-16	2019-10-18	33,250	—	$0	0	SEC↗
Truitt Joseph	Chief Executive Officer	S Sale	2019-10-16	2019-10-18	100,234	$6.37	$638.5K	36,750	SEC↗
Truitt Joseph	Chief Executive Officer	M Exercise	2019-10-16	2019-10-18	33,250	$3.28	$109.1K	136,984	SEC↗
Truitt Joseph	Chief Executive Officer	M Exercise	2019-10-16	2019-10-18	100,234	$3.10	$310.7K	103,734	SEC↗
Truitt Joseph	Chief Executive Officer	S Sale	2019-10-16	2019-10-18	33,250	$6.37	$211.8K	3,500	SEC↗
Di Donato Brian	Chief Financial Officer	A Award deriv	2019-02-11	2019-02-11	500,000	—	$0	500,000	SEC↗
VITULLO NICOLE	Director	A Award deriv	2019-01-23	2019-01-25	42,000	—	$0	42,000	SEC↗
Firuta Paul E	Chief Operating Officer	A Award deriv	2019-01-23	2019-01-25	200,000	—	$0	200,000	SEC↗
Gibney Anthony S	Chief Business Officer	A Award deriv	2019-01-23	2019-01-25	200,000	—	$0	200,000	SEC↗
Lantz Keri	See Remarks	A Award deriv	2019-01-23	2019-01-25	100,000	—	$0	100,000	SEC↗
MANNING MARTHA E	General Counsel	A Award deriv	2019-01-23	2019-01-25	150,000	—	$0	150,000	SEC↗
Truitt Joseph	Chief Executive Officer	A Award deriv	2019-01-23	2019-01-25	1,097,000	—	$0	1,097,000	SEC↗
Zelenkofske Steven	Chief Medical Officer	A Award deriv	2019-01-23	2019-01-25	200,000	—	$0	200,000	SEC↗
FISHERMAN JASON S	Director	A Award deriv	2019-01-23	2019-01-25	42,000	—	$0	42,000	SEC↗
Graves Kurt	Director	A Award deriv	2019-01-23	2019-01-25	42,000	—	$0	42,000	SEC↗
KISHBAUCH MICHAEL D	Director	A Award deriv	2019-01-23	2019-01-25	42,000	—	$0	42,000	SEC↗
Scheer David	Director	A Award deriv	2019-01-23	2019-01-25	42,000	—	$0	42,000	SEC↗
VAN NOSTRAND ROBERT L	Director	A Award deriv	2019-01-23	2019-01-25	42,000	—	$0	42,000	SEC↗
Verwiel Frank	Director	A Award deriv	2019-01-23	2019-01-25	42,000	—	$0	42,000	SEC↗
VAN NOSTRAND ROBERT L	Director	M Exercise deriv	2018-12-14	2018-12-18	20,000	—	$0	0	SEC↗
Scheer David	Director	M Exercise deriv	2018-12-14	2018-12-18	20,000	—	$0	0	SEC↗
VAN NOSTRAND ROBERT L	Director	M Exercise	2018-12-14	2018-12-18	20,000	$1.05	$21.0K	20,000	SEC↗
Scheer David	Director	M Exercise	2018-12-14	2018-12-18	20,000	$1.05	$21.0K	20,000	SEC↗
Firuta Paul E	Chief Operating Officer	A Award deriv	2018-09-11	2018-09-12	400,000	—	$0	400,000	SEC↗
Zelenkofske Steven	Chief Medical Officer	A Award deriv	2018-08-20	2018-08-21	500,000	—	$0	500,000	SEC↗
Gibney Anthony S	Chief Business Officer	A Award deriv	2018-08-15	2018-08-16	500,000	—	$0	500,000	SEC↗
FISHERMAN JASON S	Director	M Exercise deriv	2018-06-06	2018-06-08	20,000	—	$0	0	SEC↗
FISHERMAN JASON S	Director	M Exercise	2018-06-06	2018-06-08	20,000	$1.05	$21.0K	70,000	SEC↗
VITULLO NICOLE	Director	J Other	2018-05-31	2018-06-04	25,000	—	$0	0	SEC↗
VITULLO NICOLE	Director	J Other	2018-05-31	2018-06-04	5,000	—	$0	36,431	SEC↗
Truitt Joseph	Chief Executive Officer	A Award deriv	2018-05-01	2018-05-03	632,000	—	$0	632,000	SEC↗
VITULLO NICOLE	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
Verwiel Frank	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
VAN NOSTRAND ROBERT L	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
Scheer David	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
KISHBAUCH MICHAEL D	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
Graves Kurt	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
FRASHIER GARY E	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
FISHERMAN JASON S	Director	A Award deriv	2018-02-09	2018-02-13	30,000	—	$0	30,000	SEC↗
Truitt Joseph	Chief Commercial Officer	A Award deriv	2018-02-09	2018-02-13	419,000	—	$0	419,000	SEC↗
MANNING MARTHA E	General Counsel	A Award deriv	2018-02-09	2018-02-13	215,000	—	$0	215,000	SEC↗
Fenton Mary Kay	Chief Financial Officer	A Award deriv	2018-02-09	2018-02-13	250,000	—	$0	250,000	SEC↗
Deshpande Milind	Chief Executive Officer	A Award deriv	2018-02-09	2018-02-13	640,000	—	$0	640,000	SEC↗
Johnson & Johnson Innovation -	10% Owner	S Sale	2017-11-20	2017-11-22	18,367,346	$2.75	$50.51M	0	SEC↗
VITULLO NICOLE	Director	M Exercise deriv	2017-08-10	2017-08-14	20,706	—	$0	0	SEC↗
VITULLO NICOLE	Director	M Exercise deriv	2017-08-10	2017-08-14	2,790,539	—	$0	0	SEC↗
VITULLO NICOLE	Director	M Exercise	2017-08-10	2017-08-14	20,706	$3.11	$64.4K	37,885	SEC↗
VITULLO NICOLE	Director	F Tax w/h	2017-08-10	2017-08-14	1,714,954	$5.06	$8.68M	3,393,382	SEC↗
VITULLO NICOLE	Director	M Exercise	2017-08-10	2017-08-14	2,790,539	$3.11	$8.68M	5,108,336	SEC↗
VITULLO NICOLE	Director	F Tax w/h	2017-08-10	2017-08-14	12,726	$5.06	$64.4K	25,159	SEC↗
FISHERMAN JASON S	Director	W Will	2017-06-28	2017-06-30	1,500	—	$0	1,500	SEC↗
FISHERMAN JASON S	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
FRASHIER GARY E	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
Graves Kurt	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
KISHBAUCH MICHAEL D	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
Scheer David	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
VAN NOSTRAND ROBERT L	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
Verwiel Frank	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
VITULLO NICOLE	Director	A Award deriv	2017-01-19	2017-01-19	30,000	—	$0	30,000	SEC↗
Apelian David	Chief Medical Officer	A Award deriv	2017-01-17	2017-01-19	185,000	—	$0	185,000	SEC↗
Deshpande Milind	Chief Executive Officer	A Award deriv	2017-01-17	2017-01-19	458,000	—	$0	458,000	SEC↗
Barrish Joel C	Chief Scientific Officer	A Award deriv	2017-01-17	2017-01-19	185,000	—	$0	185,000	SEC↗
Fenton Mary Kay	Chief Financial Officer	A Award deriv	2017-01-17	2017-01-19	165,000	—	$0	165,000	SEC↗
MANNING MARTHA E	EVP, General Counsel	A Award deriv	2017-01-17	2017-01-19	135,000	—	$0	135,000	SEC↗
Truitt Joseph	Chief Commercial Officer	A Award deriv	2017-01-17	2017-01-19	185,000	—	$0	185,000	SEC↗
FISHERMAN JASON S	Director	P Buy	2016-12-22	2016-12-23	10,000	$3.96	$39.6K	50,000	SEC↗
Fenton Mary Kay	Chief Financial Officer	P Buy	2016-12-05	2016-12-05	2,500	$4.11	$10.3K	2,500	SEC↗
Barrish Joel C	Chief Scientific Officer	P Buy	2016-12-02	2016-12-05	2,500	$4.06	$10.1K	2,500	SEC↗
Deshpande Milind	Chief Executive Officer	P Buy	2016-12-02	2016-12-05	2,500	$4.06	$10.1K	2,500	SEC↗
MANNING MARTHA E	EVP, General Counsel	P Buy	2016-12-02	2016-12-05	2,500	$4.09	$10.2K	2,500	SEC↗
Truitt Joseph	Chief Commercial Officer	P Buy	2016-12-02	2016-12-05	3,500	$4.06	$14.2K	3,500	SEC↗
MANNING MARTHA E	EVP, General Counsel	A Award deriv	2016-02-01	2016-02-03	110,000	—	$0	110,000	SEC↗
VITULLO NICOLE	Director	A Award deriv	2016-01-25	2016-01-26	30,000	—	$0	30,000	SEC↗
Verwiel Frank	Director	A Award deriv	2016-01-25	2016-01-27	30,000	—	$0	30,000	SEC↗
VAN NOSTRAND ROBERT L	Director	A Award deriv	2016-01-25	2016-01-27	30,000	—	$0	30,000	SEC↗
Scheer David	Director	A Award deriv	2016-01-25	2016-01-27	30,000	—	$0	30,000	SEC↗
KISHBAUCH MICHAEL D	Director	A Award deriv	2016-01-25	2016-01-27	30,000	—	$0	30,000	SEC↗
Graves Kurt	Director	A Award deriv	2016-01-25	2016-01-27	30,000	—	$0	30,000	SEC↗
FRASHIER GARY E	Director	A Award deriv	2016-01-25	2016-01-27	30,000	—	$0	30,000	SEC↗
FISHERMAN JASON S	Director	A Award deriv	2016-01-25	2016-01-27	30,000	—	$0	30,000	SEC↗
Deshpande Milind	Chief Executive Officer	A Award deriv	2016-01-20	2016-01-22	400,000	—	$0	400,000	SEC↗
Fenton Mary Kay	Chief Financial Officer	A Award deriv	2016-01-20	2016-01-22	118,000	—	$0	118,000	SEC↗
Apelian David	Chief Medical Officer	A Award deriv	2016-01-20	2016-01-22	118,000	—	$0	118,000	SEC↗
Barrish Joel C	Chief Scientific Officer	A Award deriv	2016-01-20	2016-01-22	20,000	—	$0	20,000	SEC↗
Truitt Joseph	Chief Commercial Officer	A Award deriv	2016-01-20	2016-01-22	142,000	—	$0	142,000	SEC↗
Barrish Joel C	Chief Scientific Officer	A Award deriv	2016-01-04	2016-01-05	250,000	—	$0	250,000	SEC↗
Apelian David	Chief Medical Officer	M Exercise deriv	2015-12-30	2015-12-30	10,000	—	$0	290,000	SEC↗
Apelian David	Chief Medical Officer	M Exercise	2015-12-30	2015-12-30	10,000	$3.02	$30.2K	10,000	SEC↗
Apelian David	Chief Medical Officer	S Sale	2015-12-30	2015-12-30	10,000	$10.50	$105.0K	0	SEC↗
Fenton Mary Kay	Chief Financial Officer	M Exercise deriv	2015-12-28	2015-12-30	43,500	—	$0	0	SEC↗
Fenton Mary Kay	Chief Financial Officer	S Sale	2015-12-28	2015-12-30	43,500	$10.08	$438.5K	0	SEC↗
Fenton Mary Kay	Chief Financial Officer	M Exercise	2015-12-28	2015-12-30	43,500	$1.05	$45.7K	43,500	SEC↗
Verwiel Frank	Director	A Award deriv	2015-12-14	2015-12-16	30,000	—	$0	30,000	SEC↗
VITULLO NICOLE	Director	S Sale	2015-11-11	2015-11-12	49,630	$10.31	$511.7K	2,317,797	SEC↗
VITULLO NICOLE	Director	S Sale	2015-11-11	2015-11-12	370	$10.31	$3.8K	17,179	SEC↗
VITULLO NICOLE	Director	S Sale	2015-11-10	2015-11-12	1,325	$10.43	$13.8K	17,549	SEC↗
VITULLO NICOLE	Director	S Sale	2015-11-10	2015-11-12	177,749	$10.43	$1.85M	2,367,427	SEC↗
VITULLO NICOLE	Director	S Sale	2015-11-09	2015-11-12	2,375	$10.01	$23.8K	18,874	SEC↗
VITULLO NICOLE	Director	S Sale	2015-11-09	2015-11-12	318,551	$10.01	$3.19M	2,545,176	SEC↗
VITULLO NICOLE	Director	S Sale	2015-09-25	2015-09-29	69	$8.22	$567	21,249	SEC↗
VITULLO NICOLE	Director	S Sale	2015-09-25	2015-09-29	9,241	$8.22	$76.0K	2,863,727	SEC↗
VITULLO NICOLE	Director	J Other	2015-08-18	2015-08-18	483,521	—	$0	0	SEC↗
VITULLO NICOLE	Director	J Other	2015-08-18	2015-08-18	31,431	—	$0	31,431	SEC↗
VITULLO NICOLE	Director	S Sale	2015-08-14	2015-08-18	37,843	$7.51	$284.2K	21,318	SEC↗
VITULLO NICOLE	Director	J Other	2015-05-21	2015-05-22	1,700,000	—	$0	2,872,968	SEC↗
VITULLO NICOLE	Director	J Other	2015-05-21	2015-05-22	222,630	—	$0	483,521	SEC↗
Fenton Mary Kay	EVP and CFO	M Exercise deriv	2015-01-23	2015-01-23	13,125	—	$0	0	SEC↗
Fenton Mary Kay	EVP and CFO	S Sale	2015-01-23	2015-01-23	13,125	$16.00	$210.0K	0	SEC↗
Fenton Mary Kay	EVP and CFO	M Exercise	2015-01-23	2015-01-23	13,125	$4.00	$52.5K	13,125	SEC↗
Deshpande Milind	President and CEO	M Exercise deriv	2015-01-21	2015-01-23	100,000	—	$0	300,000	SEC↗
Deshpande Milind	President and CEO	S Sale	2015-01-21	2015-01-23	100,000	$15.00	$1.50M	0	SEC↗
Deshpande Milind	President and CEO	M Exercise	2015-01-21	2015-01-23	100,000	$3.02	$302.0K	100,000	SEC↗
VITULLO NICOLE	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
Deshpande Milind	President and CEO	A Award deriv	2014-12-02	2014-12-04	345,000	—	$0	345,000	SEC↗
Fenton Mary Kay	EVP and CFO	A Award deriv	2014-12-02	2014-12-04	110,000	—	$0	110,000	SEC↗
Apelian David	EVP and Chief Medical Office	A Award deriv	2014-12-02	2014-12-04	175,000	—	$0	175,000	SEC↗
Shah Gautam	EVP and Chief Compliance Ofc	A Award deriv	2014-12-02	2014-12-04	95,000	—	$0	95,000	SEC↗
Truitt Joseph	EVP, Chief Commercial Office	A Award deriv	2014-12-02	2014-12-04	110,000	—	$0	110,000	SEC↗
FISHERMAN JASON S	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
FRASHIER GARY E	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
Graves Kurt	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
KISHBAUCH MICHAEL D	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
Liotta Dennis	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
Scheer David	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
VAN NOSTRAND ROBERT L	Director	A Award deriv	2014-12-02	2014-12-04	25,000	—	$0	25,000	SEC↗
Apelian David	EVP and CMO	A Award deriv	2014-12-02	2014-12-05	175,000	—	$0	175,000	SEC↗
FISHERMAN JASON S	Director	A Award deriv	2014-12-02	2014-12-05	25,000	—	$0	25,000	SEC↗
RA Capital Healthcare Fund LP	Other	S Sale	2014-09-30	2014-10-01	411,000	$10.11	$4.16M	7,400,000	SEC↗
RA Capital Healthcare Fund LP	Other	S Sale	2014-09-30	2014-10-01	700,000	$10.02	$7.01M	6,700,000	SEC↗
RA Capital Healthcare Fund LP	Other	S Sale	2014-09-29	2014-10-01	221,014	$10.96	$2.42M	7,811,000	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-26	2014-09-26	250,000	$11.10	$2.77M	8,032,014	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-26	2014-09-26	120,000	$10.96	$1.32M	8,282,014	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-26	2014-09-26	300,000	$11.12	$3.34M	8,402,014	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-25	2014-09-26	250,000	$11.06	$2.77M	8,702,014	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-25	2014-09-26	131,800	$11.06	$1.46M	8,952,014	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-25	2014-09-26	116,186	$11.01	$1.28M	9,083,814	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-24	2014-09-26	500,000	$11.28	$5.64M	9,200,000	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-24	2014-09-26	210,109	$11.29	$2.37M	9,700,000	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-24	2014-09-26	319,100	$11.25	$3.59M	9,910,109	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-24	2014-09-26	175,720	$11.24	$1.98M	10,229,209	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-23	2014-09-23	655,239	$11.11	$7.28M	10,722,429	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-23	2014-09-23	11,783	$11.10	$130.8K	11,377,668	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-23	2014-09-23	317,500	$11.02	$3.50M	10,404,929	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-22	2014-09-23	60,549	$11.09	$671.5K	11,389,451	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-22	2014-09-23	50,000	$11.09	$554.5K	11,450,000	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-22	2014-09-23	335,140	$11.08	$3.71M	11,500,000	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-19	2014-09-23	814,860	$11.50	$9.37M	11,835,140	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-19	2014-09-23	5,900	$11.84	$69.9K	12,650,000	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-19	2014-09-23	16,387	$11.67	$191.2K	12,655,900	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-19	2014-09-23	327,713	$11.65	$3.82M	12,672,287	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	184,643	$12.41	$2.29M	13,997,269	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	531,352	$12.31	$6.54M	13,382,357	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	115,000	$12.33	$1.42M	13,267,357	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	17,357	$12.32	$213.8K	13,250,000	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	83,560	$12.62	$1.05M	13,913,709	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	250,000	$12.35	$3.09M	13,000,000	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	83,560	$12.62	$1.05M	13,913,709	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	184,643	$12.41	$2.29M	13,997,269	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	531,352	$12.31	$6.54M	13,382,357	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	115,000	$12.33	$1.42M	13,267,357	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	17,357	$12.32	$213.8K	13,250,000	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-11	2014-09-12	250,000	$12.35	$3.09M	13,000,000	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	8,600	$12.73	$109.5K	14,695,762	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	49,057	$12.69	$622.5K	14,646,705	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	273,017	$127013.00	$34.68B	14,373,688	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	69,833	$12.63	$882.0K	14,303,855	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	121,943	$12.61	$1.54M	14,181,912	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	121,943	$12.61	$1.54M	14,181,912	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	69,833	$12.63	$882.0K	14,303,855	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	273,017	$12.70	$3.47M	14,373,688	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	49,057	$12.69	$622.5K	14,646,705	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2014-09-10	2014-09-12	8,600	$12.73	$109.5K	14,695,762	SEC↗
VITULLO NICOLE	Director	J Other	2014-09-09	2014-09-11	100,995	—	$0	260,891	SEC↗
VITULLO NICOLE	Director	J Other	2014-09-09	2014-09-11	1,200,000	—	$0	4,572,968	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-02	2014-09-02	158,655	$12.04	$1.91M	14,704,362	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-02	2014-09-02	1,100	$11.93	$13.1K	14,966,069	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-09-02	2014-09-02	103,052	$12.01	$1.24M	14,863,017	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-29	2014-09-02	64,000	$11.41	$730.2K	14,967,169	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-29	2014-09-02	217,000	$11.40	$2.47M	15,031,169	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-29	2014-09-02	46,600	$11.45	$533.6K	15,248,169	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-29	2014-09-02	30,500	$11.44	$348.9K	15,294,769	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-29	2014-09-02	2,635	$11.42	$30.1K	15,359,229	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-29	2014-09-02	4,150	$11.53	$47.8K	15,361,864	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-29	2014-09-02	33,960	$11.41	$387.5K	15,325,269	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-28	2014-09-02	173,641	$11.51	$2.00M	15,366,014	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-27	2014-08-27	150,100	$11.48	$1.72M	15,539,655	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-27	2014-08-27	116,989	$11.75	$1.37M	15,689,755	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-26	2014-08-27	312,867	$11.77	$3.68M	15,806,744	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-26	2014-08-27	250,000	$11.80	$2.95M	16,269,611	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-26	2014-08-27	52,361	$11.16	$584.3K	16,519,611	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-26	2014-08-27	1,347,639	$11.13	$15.00M	16,571,972	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-26	2014-08-27	150,000	$11.78	$1.77M	16,119,611	SEC↗
Truitt Joseph	EVP, Chief Commercial Office	M Exercise deriv	2014-08-25	2014-08-26	25,000	—	$0	0	SEC↗
Truitt Joseph	EVP, Chief Commercial Office	M Exercise	2014-08-25	2014-08-26	25,000	$0.82	$20.5K	25,000	SEC↗
Truitt Joseph	EVP, Chief Commercial Office	S Sale	2014-08-25	2014-08-26	25,000	$10.82	$270.5K	0	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-25	2014-08-27	105,196	$11.01	$1.16M	17,919,611	SEC↗
RA CAPITAL MANAGEMENT, LLC	10% Owner	S Sale	2014-08-25	2014-08-27	226,200	$10.94	$2.47M	18,024,807	SEC↗
Deshpande Milind	President and CEO	M Exercise deriv	2014-08-18	2014-08-19	15,950	—	$0	0	SEC↗
Deshpande Milind	President and CEO	M Exercise deriv	2014-08-18	2014-08-19	60,000	—	$0	0	SEC↗
Deshpande Milind	President and CEO	M Exercise deriv	2014-08-18	2014-08-19	124,424	—	$0	75,576	SEC↗
Deshpande Milind	President and CEO	M Exercise deriv	2014-08-18	2014-08-19	16,250	—	$0	0	SEC↗
RA Capital Healthcare Fund LP	10% Owner	S Sale	2014-08-18	2014-08-19	235,000	$9.51	$2.23M	18,251,007	SEC↗
RA Capital Healthcare Fund LP	10% Owner	S Sale	2014-08-18	2014-08-19	50,000	$9.75	$487.5K	18,486,007	SEC↗
RA Capital Healthcare Fund LP	10% Owner	S Sale	2014-08-18	2014-08-19	415,000	$9.68	$4.02M	18,536,007	SEC↗
RA Capital Healthcare Fund LP	10% Owner	S Sale	2014-08-18	2014-08-19	400,000	$9.70	$3.88M	18,951,007	SEC↗
RA Capital Healthcare Fund LP	10% Owner	S Sale	2014-08-18	2014-08-19	635,000	$9.73	$6.18M	19,351,007	SEC↗
RA Capital Healthcare Fund LP	10% Owner	S Sale	2014-08-18	2014-08-19	258,978	$9.57	$2.48M	19,986,007	SEC↗
Deshpande Milind	President and CEO	M Exercise	2014-08-18	2014-08-19	124,424	$3.10	$385.7K	124,424	SEC↗
Deshpande Milind	President and CEO	S Sale	2014-08-18	2014-08-19	60,000	$10.00	$600.0K	0	SEC↗
Deshpande Milind	President and CEO	M Exercise	2014-08-18	2014-08-19	60,000	$3.28	$196.8K	60,000	SEC↗
Deshpande Milind	President and CEO	S Sale	2014-08-18	2014-08-19	15,950	$10.00	$159.5K	0	SEC↗
Deshpande Milind	President and CEO	S Sale	2014-08-18	2014-08-19	124,424	$10.00	$1.24M	0	SEC↗